{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:18:58Z","timestamp":1782569938865,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clnu.2020.09.043","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T02:58:32Z","timestamp":1601607512000},"page":"2169-2179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans"],"prefix":"10.1016","volume":"40","author":[{"given":"Karina V.","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svend S.","family":"Korfitzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-8508","authenticated-orcid":false,"given":"Mads H.","family":"Kaspersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-7587","authenticated-orcid":false,"given":"Elisabeth Rexen","family":"Ulven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe H.","family":"Ekberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bauer-Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8135-1755","authenticated-orcid":false,"given":"Trond","family":"Ulven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnu.2020.09.043_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.clnu.2020.09.043_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/dme.12965","article-title":"Societal costs of diabetes mellitus in Denmark","volume":"33","author":"Sortso","year":"2016","journal-title":"Diabet Med : J Br Diabet Assoc"},{"issue":"12","key":"10.1016\/j.clnu.2020.09.043_bib3","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.043_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2020.09.043_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fendo.2014.00083","article-title":"Therapeutic role and ligands of medium- to long-chain Fatty Acid receptors","volume":"5","author":"Hara","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2020.09.043_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphar.2014.00236","article-title":"Free fatty acid receptors as therapeutic targets for the treatment of diabetes","volume":"5","author":"Ichimura","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnu.2020.09.043_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00137","article-title":"Treatment of type 2 diabetes by free fatty acid receptor agonists","volume":"5","author":"Watterson","year":"2014","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.clnu.2020.09.043_bib9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543784.2016.1189530","article-title":"Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development","volume":"25","author":"Li","year":"2016","journal-title":"Expet Opin Invest Drugs"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/pr.117.014373","article-title":"G\u00a0protein-coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus","volume":"70","author":"Riddy","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"13","key":"10.1016\/j.clnu.2020.09.043_bib11","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"3\u20134","key":"10.1016\/j.clnu.2020.09.043_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prostaglandins.2009.05.003","article-title":"Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis","volume":"89","author":"Ichimura","year":"2009","journal-title":"Prostag Other Lipid Mediat"},{"issue":"6928","key":"10.1016\/j.clnu.2020.09.043_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.043_bib14","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2020.09.043_bib15","series-title":"Reviews of Physiology, Biochemistry and Pharmacology. 164","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/112_2013_13","article-title":"Free fatty acid receptors and their role in regulation of energy metabolism","author":"Hara","year":"2013"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2020.09.043_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdi.12478","article-title":"Mechanisms underlying glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion","volume":"7","author":"Reimann","year":"2016","journal-title":"J\u00a0Diabetes Invest"},{"issue":"7","key":"10.1016\/j.clnu.2020.09.043_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2020.09.043_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.13129","article-title":"Incretin hormones: their role in health and disease","volume":"20","author":"Nauck","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm1168","article-title":"Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120","volume":"11","author":"Hirasawa","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1210\/en.2014-1653","article-title":"Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion","volume":"156","author":"Iwasaki","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.043_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088227","article-title":"Expression of the fatty acid receptor GPR120 in the gut of diet-induced-obese rats and its role in GLP-1 secretion","volume":"9","author":"Paulsen","year":"2014","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.clnu.2020.09.043_bib22","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1210\/en.2016-1334","article-title":"GPR119, a major enteroendocrine sensor of dietary triglyceride metabolites coacting in synergy with FFA1 (GPR40)","volume":"157","author":"Ekberg","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.clnu.2020.09.043_bib23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.molmet.2013.08.006","article-title":"Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells","volume":"2","author":"Engelstoft","year":"2013","journal-title":"Molecular Metabol"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib24","doi-asserted-by":"crossref","first-page":"G367","DOI":"10.1152\/ajpgi.00541.2011","article-title":"Postprandial inhibition of gastric ghrelin secretion by long-chain fatty acid through GPR120 in isolated gastric ghrelin cells and mice","volume":"303","author":"Lu","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib25","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1152\/ajpendo.00306.2013","article-title":"G\u00a0protein-coupled receptor 120 signaling regulates ghrelin secretion in\u00a0vivo and in\u00a0vitro","volume":"306","author":"Gong","year":"2014","journal-title":"Am J Physiol Endocrinol Metabol"},{"issue":"5","key":"10.1016\/j.clnu.2020.09.043_bib26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.clnu.2020.09.043_bib27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm.3614","article-title":"A\u00a0Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice","volume":"20","author":"Oh","year":"2014","journal-title":"Nat Med"},{"issue":"19","key":"10.1016\/j.clnu.2020.09.043_bib28","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1021\/acs.jmedchem.6b00685","article-title":"Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity","volume":"59","author":"Azevedo","year":"2016","journal-title":"J\u00a0Med Chem"},{"issue":"11","key":"10.1016\/j.clnu.2020.09.043_bib29","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1017\/S000711451500118X","article-title":"Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1\/FFA4 agonist with potential effect against metabolic diseases","volume":"113","author":"Christiansen","year":"2015","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"5 Pt 2","key":"10.1016\/j.clnu.2020.09.043_bib31","first-page":"R1541","article-title":"Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2","volume":"276","author":"Gutzwiller","year":"1999","journal-title":"Am J Physiol"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.043_bib32","first-page":"4382","article-title":"A\u00a0meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans","volume":"86","author":"Verdich","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.043_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.14310\/horm.2002.1672","article-title":"Effects of ghrelin in energy balance and body weight homeostasis","volume":"15","author":"Mihalache","year":"2016","journal-title":"Hormones (Athens, Greece)"},{"key":"10.1016\/j.clnu.2020.09.043_bib34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-511X-7-10","article-title":"The effect of Korean pine nut oil on in\u00a0vitro CCK release, on appetite sensations and on gut hormones in post-menopausal overweight women","volume":"7","author":"Pasman","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clnu.2020.09.043_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-511X-7-6","article-title":"The effect of Korean pine nut oil (PinnoThin) on food intake, feeding behaviour and appetite: a double-blind placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-7075-8-79","article-title":"No effects of Korean pine nut triacylglycerol on satiety and energy intake","volume":"8","author":"Verhoef","year":"2011","journal-title":"Nutrition Metabol"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.043_bib37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.soard.2016.02.033","article-title":"Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor","volume":"12","author":"Holst","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2020.09.043_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/164_2016_46","article-title":"Gut hormone regulation and secretion via FFA1 and FFA4","volume":"236","author":"Gribble","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.043_bib39","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00125-013-2876-2","article-title":"A\u00a0randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes","volume":"56","author":"Ma","year":"2013","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.043_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","article-title":"Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. International journal of obesity and related metabolic disorders","volume":"24","author":"Flint","year":"2000","journal-title":"J\u00a0Int Assoc Study Obesity"},{"key":"10.1016\/j.clnu.2020.09.043_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12986-017-0164-8","article-title":"Supplementation with dairy calcium and\/or flaxseed fibers in conjunction with orlistat augments fecal fat excretion without altering ratings of gastrointestinal comfort","volume":"14","author":"Kristensen","year":"2017","journal-title":"Nutrition Metabol"},{"issue":"7","key":"10.1016\/j.clnu.2020.09.043_bib42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.043_bib43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2337\/dc06-1240","article-title":"The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance","volume":"30","author":"Hansen","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.24.3.539","article-title":"A\u00a0model-based method for assessing insulin sensitivity from the oral glucose tolerance test","volume":"24","author":"Mari","year":"2001","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.043_bib45","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.clnu.2020.09.043_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diab.25.4.241","article-title":"Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading","volume":"25","author":"Sluiter","year":"1976","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI105534","article-title":"Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus","volume":"46","author":"Seltzer","year":"1967","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clnu.2020.09.043_bib48","author":"ProductDescription_DRcaps\u2122. A matter of timing"},{"issue":"4","key":"10.1016\/j.clnu.2020.09.043_bib49","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.043_bib50","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1053\/j.gastro.2007.03.048","article-title":"Gut hormones and appetite control","volume":"132","author":"Wren","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.043_bib51","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1210\/jc.2003-031267","article-title":"Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans","volume":"89","author":"Callahan","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.clnu.2020.09.043_bib52","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/oby.21202","article-title":"Hunger and satiety responses to high-fat meals of varying fatty acid composition in women with obesity","volume":"23","author":"Stevenson","year":"2015","journal-title":"Obesity"},{"issue":"30","key":"10.1016\/j.clnu.2020.09.043_bib53","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1021\/acs.jafc.5b01626","article-title":"The fatty acid composition of virgin olive oil from different cultivars is determinant for foam cell formation by macrophages","volume":"63","author":"Quintero-Florez","year":"2015","journal-title":"J\u00a0Agric Food Chem"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142030515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S026156142030515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:08:31Z","timestamp":1759367311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S026156142030515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S026156142030515X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.043","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humans","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}